PMID- 22718544 OWN - NLM STAT- MEDLINE DCOM- 20120830 LR - 20220309 IS - 1531-8249 (Electronic) IS - 0364-5134 (Print) IS - 0364-5134 (Linking) VI - 71 IP - 6 DP - 2012 Jun TI - CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. PG - 753-64 LID - 10.1002/ana.23569 [doi] AB - OBJECTIVE: Hyperlipidemia exacerbates ischemic stroke outcome and increases CD36 expression in the postischemic brain as well as in peripheral monocytes/macrophages. By exchanging bone marrow-derived cells between CD36-expressing and CD36-deficient mice, this study investigates the contribution of peripheral CD36 in comparison with that of brain CD36 to stroke pathology in hyperlipidemia. METHODS: Following bone marrow transplantation, mice were fed a high-fat diet for 11 weeks and then subjected to ischemic stroke. Stroke outcome, expression of brain CD36, monocyte chemoattractant protein-1 (MCP-1), CCR2, and plasma MCP-1 levels were determined at 3 days postischemia. CD36 and CCR2 expression were also determined in splenocytes incubated with serum obtained from CD36-expressing or CD36-deficient mice. RESULTS: Infiltrating immune cells from the periphery are the major source of CD36 in the postischemic brain and contribute to stroke-induced brain injury. This CD36 effect was dependent on the modulation of MCP-1 and CCR2 expression in peripheral immune cells as well as CD36-expressing cells in the host brain. INTERPRETATION: This study demonstrates that CD36 expressed in the periphery and brain synergize in ischemic brain injury through regulation of the MCP-1/CCR2 chemokine axis in hyperlipidemic conditions. CI - Copyright (c) 2012 American Neurological Association. FAU - Kim, Eunhee AU - Kim E AD - Burke-Cornell Medical Research Institute, White Plains, NY. FAU - Febbraio, Maria AU - Febbraio M FAU - Bao, Yi AU - Bao Y FAU - Tolhurst, Aaron T AU - Tolhurst AT FAU - Epstein, Jeffrey M AU - Epstein JM FAU - Cho, Sunghee AU - Cho S LA - eng GR - R01 HL082511-05/HL/NHLBI NIH HHS/United States GR - R01 HL082511/HL/NHLBI NIH HHS/United States GR - HL82511-04S1/HL/NHLBI NIH HHS/United States GR - HL82511/HL/NHLBI NIH HHS/United States GR - R01 HL082511-04S1/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Ann Neurol JT - Annals of neurology JID - 7707449 RN - 0 (Arabidopsis Proteins) RN - 0 (CD36 Antigens) RN - 0 (CX3C Chemokine Receptor 1) RN - 0 (Ccl2 protein, mouse) RN - 0 (Ccr2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CX3CL1) RN - 0 (Cx3cl1 protein, mouse) RN - 0 (Cx3cr1 protein, mouse) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) RN - 97C5T2UQ7J (Cholesterol) RN - EC 5.4.- (Intramolecular Transferases) RN - EC 5.4.- (marneral synthase, Arabidopsis) SB - IM CIN - Ann Neurol. 2012 Jun;71(6):729-31. PMID: 22718541 MH - Animals MH - Arabidopsis Proteins/metabolism MH - Bone Marrow Transplantation MH - Brain/*metabolism/pathology MH - Brain Injuries/*etiology/metabolism/pathology MH - CD36 Antigens/deficiency/*physiology MH - CX3C Chemokine Receptor 1 MH - Chemokine CCL2/metabolism MH - Chemokine CX3CL1/genetics/metabolism MH - Cholesterol/blood MH - Disease Models, Animal MH - Gene Expression Regulation/*genetics MH - *Hyperlipidemias/complications/metabolism/pathology MH - Infarction, Middle Cerebral Artery/complications MH - Intramolecular Transferases/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Monocytes/immunology/metabolism/pathology MH - Receptors, CCR2/genetics/metabolism MH - Receptors, Chemokine/genetics/metabolism MH - Time Factors PMC - PMC3383818 MID - NIHMS360079 COIS- Conflict of interest None EDAT- 2012/06/22 06:00 MHDA- 2012/08/31 06:00 PMCR- 2013/06/01 CRDT- 2012/06/22 06:00 PHST- 2012/06/22 06:00 [entrez] PHST- 2012/06/22 06:00 [pubmed] PHST- 2012/08/31 06:00 [medline] PHST- 2013/06/01 00:00 [pmc-release] AID - 10.1002/ana.23569 [doi] PST - ppublish SO - Ann Neurol. 2012 Jun;71(6):753-64. doi: 10.1002/ana.23569.